company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,104175000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,104175000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30353000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30353000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,73822000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45910000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21784000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67694000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6128000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,734000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,734000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6862000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3051000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3811000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3811000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3811000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52232000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52532000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54400000.0
Medicines Co,MDCO,,0001113481,2009.0,Q2,2009-04-01,2009-06-30,2010-08-17 16:42:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,98789000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,98789000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28308000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28308000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,70481000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47358000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22464000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69822000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,659000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,151000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,151000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,810000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4007000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3197000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3197000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3197000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52298000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52298000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53300000.0
Medicines Co,MDCO,,0001113481,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 16:42:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,102088000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,102088000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28769000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28769000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,73319000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46121000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16877000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62998000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10321000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-311000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-311000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10010000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,578000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9432000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9432000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9432000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52496000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52719000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52400000.0
Medicines Co,MDCO,,0001113481,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 16:37:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,110135000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,110135000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,33568000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,33568000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,76567000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39409000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20575000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59984000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16583000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-117000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-117000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,16466000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1040000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15426000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15426000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15426000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52819000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.29
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52924000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53200000.0
Medicines Co,MDCO,,0001113481,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:59:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.29
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,105743000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,105743000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31568000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31568000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,74175000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35788000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16676000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52464000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21711000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,483000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,483000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22194000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,989000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21205000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21205000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21205000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52991000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.4
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53359000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53000000.0
Medicines Co,MDCO,,0001113481,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:19:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.4
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,119679000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,119679000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,35394000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,35394000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,84285000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37372000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31113000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68485000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15800000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-322000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-322000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15478000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-43094000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,58572000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,58572000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,58572000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52842000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.11
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53184000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.1
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52800000.0
Medicines Co,MDCO,,0001113481,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.11
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,112137000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,112137000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,35570000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,35570000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,76567000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37928000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23792000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61720000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14847000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18795000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,18795000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33642000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9401000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24241000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24241000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24241000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53224000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54109000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52700000.0
Medicines Co,MDCO,,0001113481,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:45:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,119591000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,119591000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,37830000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,37830000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81761000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41420000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26536000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67956000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13805000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,61000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,61000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13866000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2426000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11440000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11440000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11440000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53441000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54314000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54500000.0
Medicines Co,MDCO,,0001113481,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 15:59:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,120773000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,120773000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39459000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39459000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81314000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45353000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26550000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71903000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9411000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,578000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,578000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9989000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-62625000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,72614000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,72614000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,72614000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53534000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.36
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54260000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.34
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53400000.0
Medicines Co,MDCO,,0001113481,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:13:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.36
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,132231000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,132231000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,44007000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,44007000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,88224000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34916000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33302000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68218000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20006000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,340000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,340000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20346000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,764000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19582000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19582000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19582000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53496000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54407000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53500000.0
Medicines Co,MDCO,,0001113481,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,126610000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,126610000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,38663000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,38663000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,87947000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43186000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32778000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,75964000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11983000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,62000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,62000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12045000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4474000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7571000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7571000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7571000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54037000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.14
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55672000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.14
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54100000.0
Medicines Co,MDCO,,0001113481,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 15:25:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.14
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,135702000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,135702000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,42681000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,42681000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,93021000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40467000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32962000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73429000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,19592000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,784000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2500000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,697000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2413000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22005000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8251000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13754000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13755000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13754000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54035000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55556000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55000000.0
Medicines Co,MDCO,,0001113481,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 12:06:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,136786000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,136786000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43767000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43767000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,93019000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43396000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34536000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77932000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15087000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3605000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3750000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,204000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,349000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15436000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6172000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9264000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9265000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9264000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52896000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55145000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51500000.0
Medicines Co,MDCO,,0001113481,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 15:00:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,159490000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,159490000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,52228000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,52228000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,107262000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44704000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26147000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,70851000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,36411000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3616000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3750000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,177000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,311000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36722000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16141000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20581000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20663000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,82000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20581000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53545000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55346000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53300000.0
Medicines Co,MDCO,,0001113481,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,155753000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,155753000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,56714000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,56714000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,99039000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,63482000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,58196000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,121678000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22639000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3674000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3750000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,198000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,274000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22365000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-10759000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11606000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11573000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,33000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11606000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54047000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54047000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55300000.0
Medicines Co,MDCO,,0001113481,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 14:40:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,172826000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,172826000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,63938000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,63938000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,108888000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52944000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27025000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79969000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28919000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3704000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4068000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,605000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,969000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,29888000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11854000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18034000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18094000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,60000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18034000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55553000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.33
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60261000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54600000.0
Medicines Co,MDCO,,0001113481,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:15:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.33
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,174282000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,174282000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,65794000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,65794000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,108488000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62528000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23187000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,85715000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22773000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3765000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4423000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,383000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1041000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,23814000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16068000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7746000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,47000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7793000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,47000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7746000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59231000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63173000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59600000.0
Medicines Co,MDCO,,0001113481,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:41:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,121747000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,121747000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30190000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30190000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,91557000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68869000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29852000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,98721000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7164000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4388000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5142000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,234000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,988000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6176000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-14890000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8714000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-7628000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-140000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,946000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-345000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-47000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1338000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58096000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62652000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57500000.0
Medicines Co,MDCO,,0001113481,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,177235000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,177235000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,66867000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,66867000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,110368000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64521000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31096000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,95617000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14751000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3860000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6020000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,179000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2339000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17090000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22095000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5005000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5005000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4996000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64152000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64152000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62500000.0
Medicines Co,MDCO,,0001113481,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:19:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,183774000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,183774000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,85687000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,85687000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,98087000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,88745000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,41228000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,129973000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31886000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3892000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7326000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-150000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3284000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28602000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-23428000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5174000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5174000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-17000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5157000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64400000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64400000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64500000.0
Medicines Co,MDCO,,0001113481,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:08:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,172401000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,172401000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,69076000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,69076000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,103325000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,82662000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33314000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,115976000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12651000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3958000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1680000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7553000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9831000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22482000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5693000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16789000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16789000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-53000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16736000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64534000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64534000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64400000.0
Medicines Co,MDCO,,0001113481,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:03:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,126280000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,126280000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11700000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11700000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,114580000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,79026000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33874000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,112900000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1680000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3991000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7499000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,26678000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,30186000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,31866000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4717000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27149000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-32529000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5380000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-59000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5321000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64473000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66668000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64400000.0
Medicines Co,MDCO,,0001113481,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,110115000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,110115000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20538000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20538000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,89577000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,80785000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23283000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,104068000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14491000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8615000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8244000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,23208000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,22837000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8346000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4001000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4345000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,661000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5006000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-28000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5034000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65174000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66929000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62900000.0
Medicines Co,MDCO,,0001113481,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:38:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,74519000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,74519000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24756000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24756000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,49763000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,93309000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33035000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,126344000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-76581000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9348000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20411000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,231000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11294000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-65287000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2105000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-67392000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,20853000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46539000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,53000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-46592000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65903000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65903000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65600000.0
Medicines Co,MDCO,,0001113481,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 06:54:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57206000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57206000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,49188000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,49188000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8018000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,86892000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27102000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,113994000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-105976000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9547000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,985000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4911000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3651000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-109627000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-19001000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-90626000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-14515000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-105141000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-105132000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67137000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.57
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67137000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.57
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67000000.0
Medicines Co,MDCO,,0001113481,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 07:35:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.57
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52707000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52707000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9504000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9504000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43203000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24314000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6968000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31282000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11921000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9582000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,265000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-565000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9882000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2039000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-16838000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18877000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-224949000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-206072000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-6000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-206066000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66809000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.08
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66809000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.08
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66800000.0
Medicines Co,MDCO,,0001113481,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.08
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50306000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50306000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18797000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18797000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31509000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,79298000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33491000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,112789000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-81280000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9746000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,975000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-262000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9033000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-90313000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-90359000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-2105000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-92464000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-16000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-92448000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69210000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.34
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69210000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.34
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69000000.0
Medicines Co,MDCO,,0001113481,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:47:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.34
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,54731000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,54731000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15230000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15230000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39501000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,94158000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37567000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,131725000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-92224000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15743000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1341000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,288439000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,274037000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,181813000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,181802000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,619000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,182421000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-21000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,182442000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69711000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.62
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72509000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.52
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69600000.0
Medicines Co,MDCO,,0001113481,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:23:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.62
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37599000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37599000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20777000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20777000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16822000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,69022000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23537000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,92559000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-75737000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12089000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,757000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,865000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10467000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-86204000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,163000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-86367000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,96000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-86271000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-86258000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70194000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.23
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70194000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.23
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70100000.0
Medicines Co,MDCO,,0001113481,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 06:19:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.23
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,525000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,525000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5849000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5849000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-5324000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-29996000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-2488000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-32484000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,27160000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12265000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,781000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-395000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11879000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15281000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-153000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15434000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-138292000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-122858000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-122854000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69909000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.76
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73022000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.58
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69700000.0
Medicines Co,MDCO,,0001113481,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.76
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17465000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17465000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9978000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9978000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7487000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40457000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26444000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66901000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-59414000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12422000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,757000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,111000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11554000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-70968000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-70996000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-31674000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-102670000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-102670000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71073000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.44
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71073000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.44
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71300000.0
Medicines Co,MDCO,,0001113481,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:00:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.44
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10861000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10861000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12490000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12490000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-1629000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28359000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23249000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,329097000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,380705000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-382334000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12521000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,757000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1033000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10731000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-393065000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-23000000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-370065000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-27203000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-397268000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-397268000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71918000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.53
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71918000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.53
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71800000.0
Medicines Co,MDCO,,0001113481,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 09:08:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.53
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7868000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7868000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4287000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4287000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3581000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33765000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33077000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66842000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-63261000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11810000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,769000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,448000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10593000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-73854000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-66600000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7218000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-22957000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30175000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30175000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72286000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.42
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72286000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.42
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71800000.0
Medicines Co,MDCO,,0001113481,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 17:03:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8595000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8595000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20438000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20438000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-11843000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29644000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,55600000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,63000000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,148244000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-160087000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11811000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5266000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,248000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6297000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-166384000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-7004000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-159416000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-18844000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-178260000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-178260000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72356000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.4
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72356000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.4
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72400000.0
Medicines Co,MDCO,,0001113481,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.4
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7771000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7771000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2737000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2737000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5034000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28951000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40366000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69317000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-64283000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12077000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-29761000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2369000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39469000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-103752000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-18916000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-84836000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,113985000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,29149000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,29149000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73802000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73802000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.39
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74700000.0
Medicines Co,MDCO,,0001113481,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 07:32:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1667000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1667000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2931000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2931000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-1264000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21013000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30294000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51307000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-52571000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12108000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3220000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1053000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14275000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-66846000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-12393000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54453000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,256000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54197000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-54197000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73349000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.74
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73349000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.74
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73200000.0
Medicines Co,MDCO,,0001113481,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 16:31:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.74
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-3300000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-3300000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,890000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,890000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-4190000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6826000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32736000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,5073000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44635000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48825000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12313000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-7682000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1119000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18876000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-67701000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-16066000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51635000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-3999000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55634000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-55634000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73544000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.75
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73544000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.75
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74200000.0
Medicines Co,MDCO,,0001113481,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 16:51:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.75
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,697000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,697000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-697000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-4576000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29611000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25035000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25732000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12913000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-10199000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1039000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22073000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-47805000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3513000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44292000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1818000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42474000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42474000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73571000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73571000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73300000.0
Medicines Co,MDCO,,0001113481,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16982000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27011000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43993000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-43993000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16024000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-266000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,421000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15869000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-59862000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59865000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59865000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59865000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74463000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.8
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74463000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.8
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74800000.0
Medicines Co,MDCO,,0001113481,2019.0,Q1,2019-01-01,2019-03-31,2019-04-26 07:32:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.8
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19889000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28112000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48001000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48001000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15791000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2057000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1687000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12047000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-60048000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-60055000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-60055000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-60055000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74809000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.8
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74809000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.8
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75100000.0
Medicines Co,MDCO,,0001113481,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 16:31:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.8
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18599000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42770000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61369000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-61369000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16212000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2509000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1088000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12615000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-73984000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-73994000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-73994000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-73994000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,80129000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.92
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,80129000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.92
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,80400000.0
Medicines Co,MDCO,,0001113481,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:51:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.92
